Author: devcuration

Heat has a way of telling the truth. It exposes weak infrastructure, lazy assumptions, and every datacenter design that thought yesterday’s air could survive tomorrow’s compute. Accelsius exists because AI and HPC stopped asking nicely. Founded in 2022 by Innventure, Inc., this Austin-based company stepped into a world where racks are pushing 130 kW, cooling eats up to 40% of facility power, and everyone is pretending that incremental fixes will hold. They won’t. Air is done auditioning for relevance. Accelsius secured $65M in Series B funding, led by Johnson Controls, with strategic participation from Legrand. Stack that with the $40M…

In 2020, while most people were learning how to mute themselves on Zoom, Inquis Medical quietly set up shop in Menlo Park with a very specific problem in its sights. Venous thromboembolic disease is not theoretical, not rare, and not forgiving. Pulmonary embolism and deep vein thrombosis do not wait for consensus or convenience. They demand speed, precision, and respect for blood. That is the lane Inquis Medical chose, and they stayed in it. Vahid Saadat and Mojgan Saadat did not arrive here by accident. This is what happens when two medical device operators with real scar tissue decide to…

Juvena Therapeutics did not wake up one morning and decide to chase muscle. This story starts in 2017 inside UC Berkeley labs, where Hanadie Yousef, PhD was deep in aging biology, protein signaling, and a stubborn question most people ignored: why tissue slowly forgets how to heal. That question turned into a company built on one clear belief. If aging breaks communication, regeneration begins by restoring the signal. Redwood City became home base, human stem cells became the source code, and Juvena Therapeutics became the kind of company that moves quietly until the data speaks louder than the pitch. That…

Aspen Power did not show up to make noise. It showed up to make electrons behave, capital behave, and markets behave, which is harder than it sounds and way more interesting. Founded in 2020 and incubated inside Energy Impact Partners, when $2.5B+ was already moving through the decarbonization bloodstream, this platform was built with intention, not vibes. You can feel it in the way the company moves, steady, disciplined, allergic to shortcuts, allergic to chaos. The founding lineup matters. Jorge E. Vargas, Scott Delaney, David Berv, Dan Gulick, and Jackson Lehr came in carrying $1B+ in renewable energy finance experience…

RxAnte just pulled another clean fill, and anyone paying attention to pharmacy care management knows this was not luck, hype, or timing. This was inevitability meeting preparation. A strategic growth investment from Primus Capital is the market quietly admitting what the data has been whispering for years. Medication use is the most expensive game of telephone in healthcare, and RxAnte has been the one actually listening, calculating, and calling back with receipts. Founded in 2011 by Joshua S. Benner, PharmD, ScD and Loren Lidsky, MS, RxAnte never chased noise. They chased signal. Built on analytics, policy fluency, and lived experience…

JetZero just pulled in $175M for its Series B, and if that number feels heavy, it should. Aerospace is not a hobby sport. It is gravity, physics, patience, and cash, in that order. Long Beach, CA has seen aircraft legends come and go, but this one feels different because JetZero is not chasing nostalgia. It is chasing math. Lift over drag. Fuel burn over ego. A blended wing that actually blends ambition with discipline. Founded in Sept 2020, JetZero was never about building a prettier tube. Tom O’Leary brought startup muscle and commercial instincts sharpened at Tesla and BETA Technologies,…

Morgan Stanley crypto ETFs moved from speculation to documentation as the firm filed two Form S-1 registrations with the SEC. Morgan Stanley Bitcoin Trust. Morgan Stanley Solana Trust. No white labeling. No outside issuers. This was the firm stepping forward as principal, putting its own balance sheet reputation behind regulated crypto exposure and letting the market read the nameplate slowly. This is not a casual move from a firm with $1.8T inside Morgan Stanley Investment Management and $6.2T moving through its wealth platform. For the first time, a major U.S. bank is seeking approval to issue crypto ETPs directly, extending…

The NVIDIA Intel partnership just crossed from rivalry into alignment. After more than three decades circling the same customers with different weapons, NVIDIA and Intel bent the arc of competition on September 18, 2025, when NVIDIA committed $5B for Intel common stock at $23.28 per share. The purchase locked in roughly a 4% ownership position and launched a multi-generation co-development deal that shifts the physics of modern computing. This was not a rescue check and it was not nostalgia for x86. Jensen Huang does not deploy $5B by accident. NVIDIA already owns more than 90% of the AI GPU market…

OpenAI infrastructure ownership just became explicit. SoftBank Group did not just send $40B to OpenAI Group PBC, it crossed a line global capital rarely crosses without hesitation. When the final $22.5B cleared on Dec. 26, Masayoshi Son pushed SoftBank’s ownership beyond 10%, landing near 11% of the most consequential AI company on the board. This was not portfolio management. This was conviction with teeth. Nvidia stock was sold. T Mobile trimmed. Arm Holdings leaned on. Son made the bet public and permanent. OpenAI, founded in 2015 and headquartered in SF, has outgrown the label of model lab. Under Sam Altman,…

Crypto IPO execution is no longer theoretical. On Schwab Network’s Trading 360, C1 Fund CEO Dr. Najam Kidwai laid out why 2026 is shaping up as the year public listings return to digital assets, not as spectacle, but as capital markets events. January 2, 2026. No hype music, no crypto cosplay, no verbal gymnastics. Just a clean set and Kidwai speaking in complete thoughts about a market that finally grew into its balance sheet. When he talks crypto IPOs, it carries weight because he is allocating capital inside a public, SEC-regulated structure where words have consequences and filings follow. Dr.…